Patricia Schlagenhauf

Summary

Affiliation: University of Zurich
Country: Switzerland

Publications

  1. ncbi Sex and gender differences in travel-associated disease
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, World Health Organisation Collaborating Centre for Travellers Health, University of Zurich, Zurich, Switzerland
    Clin Infect Dis 50:826-32. 2010
  2. ncbi Selected bibliography
    Patricia Schlagenhauf
    Institute for Social and Preventive Medicine, University of Zurich, Switzerland
    J Travel Med 11:391-2. 2004
  3. ncbi Selected bibliography
    Patricia Schlagenhauf
    J Travel Med 11:333-5. 2004
  4. ncbi Malaria: from prehistory to present
    Patricia Schlagenhauf
    Institute for Social and Preventive Medicine, University of Zurich, Sumatrastrasse 30, 8006 Zurich, Switzerland
    Infect Dis Clin North Am 18:189-205, table of contents. 2004
  5. ncbi Selected bibliogaphy
    Patricia Schlagenhauf
    J Travel Med 11:133-4. 2004
  6. ncbi Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    BMJ 327:1078. 2003
  7. ncbi Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, Center for Travel Medicine, University of Zurich, Zurich, Switzerland
    J Travel Med 16:42-5. 2009
  8. ncbi Profile of travel-associated illness in children, Zürich, Switzerland
    Thomas Hunziker
    University of Zurich Centre for Travel Medicine, World Health Organisation Collaborating Centre for Travellers Health, University of Zurich, Zurich, Switzerland
    J Travel Med 19:158-62. 2012
  9. ncbi Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, University of Zurich Centre for Travel Medicine, Institute for Social and Preventive Medicine, Zurich, Switzerland
    Clin Infect Dis 54:e124-31. 2012
  10. ncbi Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, Hirschengraben 84, 8001 Zurich, Switzerland
    Malar J 10:292. 2011

Detail Information

Publications20

  1. ncbi Sex and gender differences in travel-associated disease
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, World Health Organisation Collaborating Centre for Travellers Health, University of Zurich, Zurich, Switzerland
    Clin Infect Dis 50:826-32. 2010
    ..No systematic studies exist on sex and gender differences across a broad range of travel-associated diseases...
  2. ncbi Selected bibliography
    Patricia Schlagenhauf
    Institute for Social and Preventive Medicine, University of Zurich, Switzerland
    J Travel Med 11:391-2. 2004
  3. ncbi Selected bibliography
    Patricia Schlagenhauf
    J Travel Med 11:333-5. 2004
  4. ncbi Malaria: from prehistory to present
    Patricia Schlagenhauf
    Institute for Social and Preventive Medicine, University of Zurich, Sumatrastrasse 30, 8006 Zurich, Switzerland
    Infect Dis Clin North Am 18:189-205, table of contents. 2004
    ..In the year 2003 the genomes for humans, mosquito, and Plasmodium have been completed, but no malaria vaccine is available as yet...
  5. ncbi Selected bibliogaphy
    Patricia Schlagenhauf
    J Travel Med 11:133-4. 2004
  6. ncbi Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    BMJ 327:1078. 2003
    ..To compare the tolerability of malaria chemoprophylaxis regimens in non-immune travellers...
  7. ncbi Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, Center for Travel Medicine, University of Zurich, Zurich, Switzerland
    J Travel Med 16:42-5. 2009
    ..To objectively compare the mood profiles of users of malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine) in a group of nonimmune tourists to sub-Saharan Africa...
  8. ncbi Profile of travel-associated illness in children, Zürich, Switzerland
    Thomas Hunziker
    University of Zurich Centre for Travel Medicine, World Health Organisation Collaborating Centre for Travellers Health, University of Zurich, Zurich, Switzerland
    J Travel Med 19:158-62. 2012
    ..Defining the profile of reported travel-associated illnesses will help to improve the prevention and treatment of such illnesses in children...
  9. ncbi Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy
    Patricia Schlagenhauf
    Division of Epidemiology and Communicable Diseases, University of Zurich Centre for Travel Medicine, Institute for Social and Preventive Medicine, Zurich, Switzerland
    Clin Infect Dis 54:e124-31. 2012
    ..Pregnant women who travel to malarious areas and their clinicians need data on the safety of malaria chemoprophylaxis...
  10. ncbi Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, Hirschengraben 84, 8001 Zurich, Switzerland
    Malar J 10:292. 2011
    ..Use of anti-malarial medication in children is hampered by a paucity of dosage, pharmacokinetic and tolerability data...
  11. ncbi Standby emergency treatment of malaria in travelers: experience to date and new developments
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    Expert Rev Anti Infect Ther 10:537-46. 2012
    ....
  12. ncbi Imported malaria in children in industrialized countries, 1992-2002
    Katrin Stäger
    University of Zurich, Zurich, Switzerland
    Emerg Infect Dis 15:185-91. 2009
    ..Returning to country of origin to visit friends and relatives was a risk factor. Malaria prevention for children should be a responsibility of healthcare providers and should be subsidized for low-income travelers to high-risk areas...
  13. ncbi The position of mefloquine as a 21st century malaria chemoprophylaxis
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, Hirschengraben 84, University of Zurich, Switzerland
    Malar J 9:357. 2010
    ..Malaria chemoprophylaxis prevents the occurrence of the symptoms of malaria. Travellers to high-risk Plasmodium falciparum endemic areas need an effective chemoprophylaxis...
  14. ncbi Imported infectious disease and purpose of travel, Switzerland
    Lukas Fenner
    University of Zurich, Zurich, Switzerland
    Emerg Infect Dis 13:217-22. 2007
    ..364 per 1,000 ill returnees). Travel to sub-Saharan Africa contributed most to malaria in VFR travelers. In countries with large migrant populations, improved public health strategies are needed to reach VFR travelers...
  15. ncbi The risk of malaria in travelers to India
    Sabine Schmid
    Center for Travel Medicine, WHO Collaborating Center for Travelers Health, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    J Travel Med 16:194-9. 2009
    ..Several countries have reported a decline in malaria cases imported by travelers returning from India...
  16. ncbi Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa
    Lukas L Widmer
    University of Zurich Centre for Travel Medicine, WHO Collaborating Centre for Travellers Health, Hirschengraben 84, 8001 Zurich, Switzerland
    BMC Infect Dis 10:279. 2010
    ....
  17. ncbi Knowledge, attitudes, and practices of business travelers regarding influenza and the use of antiviral medication
    Salome Helfenberger
    University of Zurich Center for Travel Medicine, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    J Travel Med 17:367-73. 2010
    ..This study aimed to determine the knowledge, attitudes, and practices of Swiss business travelers with regard to influenza and the use of antiviral medication...
  18. ncbi Malaria chemoprophylaxis: strategies for risk groups
    Patricia Schlagenhauf
    University of Zurich Centre for Travel Medicine, WHO Collaborating Centre for Travellers Health, Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    Clin Microbiol Rev 21:466-72. 2008
    ..So far, malaria prophylaxis is recommended to prevent Plasmodium falciparum infections, and primaquine prophylaxis against persistent Plasmodium vivax and Plasmodium ovale infections in travelers is not recommended...
  19. ncbi Deaths caused by malaria in Switzerland 1988-2002
    Daniel Christen
    University of Zurich Travel Clinic, Institute for Social and Preventive Medicine, Zurich, Switzerland
    Am J Trop Med Hyg 75:1188-94. 2006
    ..Rapid malaria tests may be a useful diagnostic adjunct in centers where microscopic expertise is lacking. Falciparum malaria in a non-immune patient is an emergency requiring immediate treatment...
  20. ncbi Knowledge, attitudes and practices of business travelers regarding malaria risk and prevention
    Roger Weber
    Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    J Travel Med 10:219-24. 2003
    ..The knowledge, attitudes and practices of business travelers with regard to malaria prevention need to be improved...